Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Objective</h3><p>To characterize the nature and prevalence of cognitive disorders in older adults with temporal lobe epilepsy (TLE) and compare their cognitive profiles to patients with amnestic mild cognitive impairment (ie, aMCI).</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Seventy‐one older patients with TLE, 77 aMCI, and 69 normal aging controls (NACs), all 55‐80 years of age, completed neuropsychological measures of memory, language, executive function, and processing speed. An actuarial neuropsychological method designed to diagnose MCI was applied to individual patients to identify older adults with TLE who met diagnostic criteria for MCI (TLE‐MCI). A linear classifier was performed to evaluate how well the diagnostic criteria differentiated patients with TLE‐MCI from aMCI. In TLE, the contribution of epilepsy‐related and vascular risk factors to cognitive impairment was evaluated using multiple regression.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Forty‐three TLE patients (60%) met criteria for TLE‐MCI, demonstrating marked deficits in both memory and language. When patients were analyzed according to age at seizure onset, 63% of those with an early onset (<50 years) versus 56% of those with late onset (≥ 50 years) met criteria for TLE‐MCI. A classification model between TLE‐MCI and aMCI correctly classified 81.1% (90.6% specificity, 61.3% sensitivity) of the cohort based on neuropsychological scores. Whereas TLE‐MCI showed greater deficits in language relative to aMCI, patients with aMCI showed greater rapid forgetting on memory measures. Both epilepsy‐related risk factors and the presence of leukoaraiosis on MRI contributed to impairment profiles in TLE‐MCI.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Significance</h3><p>Cognitive impairment is a common comorbidity in epilepsy and it presents in a substantial number of older adults with TLE. Although the underlying etiologies are unknown in many patients, the TLE‐MCI phenotype may be secondary to an accumulation of epilepsy and vascular risk factors, signal the onset of a neurodegenerative disease, or represent a combination of factors.</p></section>

Late-onset epilepsy clinic: From clinical diagnostics to biomarkers

Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer's disease biomarkers

Temporal lobe dysfunction in late-onset epilepsy of unknown origin

Presumed aetiologies and clinical outcomes of non‐lesional late‐onset epilepsy

Overlapping and distinct phenotypic profiles in Alzheimer's disease and late onset epilepsy: a biologically-based approach

Late-onset seizures and epilepsy: Electroclinical features suggestive of autoimmune etiology

Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums

Effect of late-onset epilepsy on cognitive functioning in patients with small vessel disease

Excess health care use is significantly and persistently reduced following diagnosis of late‐onset epilepsy

Bidirectional relationship between late-onset epilepsy (LOE) and dementia: A systematic review and meta-analysis of cohort studies

Clinical features and prognosis of epilepsy in the elderly in western China.

Long-term cognitive outcomes in patient with epilepsy

Diagnosing cognitive disorders in older adults with epilepsy

The aging brain and late onset drug-refractory epilepsies

Multi-class Modeling Identifies Shared Genetic Risk for Late-onset Epilepsy and Alzheimer's Disease

Neurobehavioral problems in children with early-onset epilepsy: A population-based study

Advances in the development of biomarkers for epilepsy

Developmental and epileptic encephalopathies

A Rare Cause of Late-Onset Epilepsy: Linear Scleroderma en Coup de Sabre

Association of cognitive and structural correlates of brain aging and incident epilepsy. The Framingham Heart Study

Association of Plasma Aβ42/Aβ40 Ratio and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study